CSIRO, Molecular and Health Technologies.
Post author: Tom Peat. Last update: 29/10/2015 at 4:46 pm by Tom Peat.
There are no special offers.
The fragment screening program is more of a capability than a physical facility. The program encompasses and uses the Biomolecular Interaction Facility and the Bio21 Crystallisation Centre to screen libraries of fragments as the first step towards rational drug design.
- Access to the Australian synchrotron.
- NCRIS Protein Production Facility.
- Research collaboration.
- Fee for service.
- X-ray crystallography.
Expertise:Availability of technical support:
Note that this material was imported form the Victorian Bioportal and content requires updating.